Other important risk factors for the development of osteonecrosis include local infection, chemotherapy, steroid use, trauma, and periodontal disease. Since 2003, multiple cases of bisphosphonateinduced osteonecrosis of the jaw onj were reported. Bisphosphonaterelated osteonecrosis of jaws in advanced. Onjbp is the correct term, recently emerged, to describe a significant complication in a subset of patients receiving drugs such as zoledronic acid, pamidronate, and alendronate. The management of patients with bisphosphonate induced osteonecrosis of the jaws is quite challenging.
A diagnosis of bisphosphonateassociated osteonecrosis of the jaw relies on three criteria. In conclusion, is necessary to know this condition for an early diagnosis and treatment, so to prevent its apparition. Bisphosphonate dental care protocol bisphosphonates and osteonecrosis of the jaw. Osteonecrosis of the jaw in patients treated with bisphosphonates is a relatively rare but well known complication at maxillofacial units around the world. All the lesions encountered in this study were refractory to any kind of treatment elsewhere, such as longterm antibiotic therapy, surgical debridementsequestrectomy and hyperbaric.
Bisphosphonate induced osteochemonecrosis of the jaw. If youre looking for a free download links of bisphosphonates and osteonecrosis of the jaw. Pdf bisphosphonateinduced osteonecrosis of the jaws. Bisphosphonates related osteonecrosis of the jaw bronj is related to the development of avascular osteonecrosis or osteochemonecrosis 1, 2. Pdf bisphosphonateinduced exposed bone osteonecrosis. Bps induced osteonecrosis of the jaw onj is a relatively rare but severe. Pdf comparison of nonexposed and exposed bisphosphonate. The groups of patients most likely to present in primary care with an oral bisphosphonate associated osteonecrosis. The osteonecrosis of the jaw is a new emergent disease, secondary to prolonged use of bisphosphonates. Further research is needed to increase knowledge about the underlying mechanisms and risk factors for onj, and about. Accumulating evidence suggests that bone aging is associated with oxidative stress os, and os is associated with osteone crosis. The frequency of osteonecrosis of the jaws associated with dental implants is unknown.
Bisphosphonates are important drugs that are increasingly prescribed to reduce the morbidity associated with osteoclastmediated bone diseases. Bp induced osteonecrosis of maxilla in a patient who was on a low dose oral bp. Oral surgical intervention and female gender increase the risk of the disease. Jul 28, 2007 bisphosphonates are a class of drugs that reduce the rate of bone turnover.
A medical rarity about a decade ago, osteonecrosis of the jaw has been observed since 2003 in patients receiving high doses of nitrogen containing bisphosphonates. The reported incidence of bronj is significantly higher with the iv preparations zoledronic acid and pamidronate while the risk appears to be minimal for. Medicationrelated osteonecrosis of the jaw2014 update special committee on medication related osteonecrosis of the jaws. Just as an extraction requires bone turnover to heal, dental implants require bone turnover to maintain osseointegration.
Since the first article about bisphosphonaterelated osteonecrosis of the jaw bronj was. Oral bisphosphonate related osteonecrosis of the jaw. Currently, an exposed area of necrotic jaw bone present for at least eight weeks in patients using bisphosphonates. Osteonecrosis of the jaws and bisphosphonates springerlink. This article is from journal of clinical and experimental dentistry, volume 4. Imaging findings of bisphosphonateassociated osteonecrosis. Osteonecrosis of the jaw and bisphosphonates in cancer. Biphosphonates in the treatment of bone metastases springerlink. Article information, pdf download for risk factors for osteonecrosis of the.
Bionj is commonly precipitated by a tooth extraction in patients treated with long term, potent, high dose intravenous bisphosphonates for the management of myeloma, breast or prostate. Osteonecrosis of the jaws associated with bisphosphonate therapy was first identified in 2003 as a condition typified by exposed bone that does not heal after 8 weeks. Bisphosphonate related osteonecrosis of the jaws bronj is mainly observed in patients with multiple myeloma and bone metastasis from solid tumors receiving iv bisphosphonate therapy. Bisphosphonates, drugs that decrease bone turnover by inhibiting osteoclastmediated bone resorption, are used to treat osteoporosis, paget disease, pain from osseous metastases, and malignancyrelated hypercalcemia. Bisphosphonate related osteonecrosis of the jaws bronj is a wellknown challenging entity warranting management. Oral bisphosphonates are the most commonly prescribed antiresorptive drugs for the treatment of osteoporosis. Why worry about bisphosphonaterelated osteonecrosis of the jaw. All nitrogencontaining bisphosphonates pose a risk, which is related to the route of administration, the potency of the bisphosphonate, and the duration of use. Bisphosphonates are fairly safe drugs to be used in the long term. Although there have been some reports in the literature about osteonecrosis caused by steroids, this form is different from onj in the sense that steroidinduced. Osteonecrosis of the jaws is a major complication associated with long. Bisphosphonates inhibit bone resorption and thus bone renewal by suppressing the recruitment and activity of osteoclasts thus shortening their life span.
Although this has generated a large amount of literature in the last few years, it is difficult to. Bisphosphonates, when attached to bone tissue, are released by osteoclasts, the bone cells that break down bone tissue. Evolution and etiopathogenesis of bisphosphonates induced. Bisphosphonateassociated osteonecrosis of the jaws. Bionj is commonly precipitated by a tooth extraction in patients treated with long term, potent, high dose intravenous bisphosphonates for the management of. Osteonecrosis of the jaw, however, can occur during treatment.
Bronj is a disease entity which has only been described relatively recently, and its multi. Page 1 medicationrelated osteonecrosis of the jaw 2014 update. Ruggiero, dmd, md, clinical professor, division of oral and maxillofacial surgery, stony brook school of dental medicine, hofstra north shorelij school of medicine, new york center for orthognathic and maxillo. The present study retrospectively evaluated the clinical characteristics and evolution of bronj cases that were diagnosed and treated at a dental school from 2004 to 2011. Nih funding opportunities and notices in the nih guide for grants and contracts. Bisphosphonate induced osteonecrosis of the jaw a new disease with possible orthopedic implications there is an alarming new pathologic entity recently recognized in the jaws, which is reminiscent and comparable to osteoradionecrosis orn. Bisphosphonateinduced avascular osteonecrosis of the jaws. Osteonecrosis of the jaws in patients treated with. Oral and intravenous bisphosphonate induced osteonecrosis of. Medicationrelated osteonecrosis of the jaw in patients. While osteonecrosis can arise from other precipitating conditions, bisphosphonate. Download bisphosphonates and osteonecrosis of the jaw.
Evidence has emerged that bisphosphonate use in cancer patients is associated with osteonecrosis of the jaw. The main indications for the use of bps are for the treatment of postmenopausal osteoporosis, steroidinduced osteoporosis, pagets disease, and the. The following protocols have been developed by the bc cancer agency department of oral oncology. Osteonecrosis of the jaw induced by administration of bisphosphonates bps, bprelated osteonecrosis bronj, typically develops after tooth. Prevention of tooth extractiontriggered bisphosphonaterelated. Conclusion bisphonates associated jaw necrosis and its relation to. Our final diagnosis was zoledronic acid related osteonecrosis of the jaw.
Although bisphosphonates have been used clinically for more. Bisphosphonate bp related osteonecrosis of the jaw. However, there are several adverse effects associated with oral bisphosphonates including the bisphosphonate related osteonecrosis of the jaw bronj. Bisphosphonate associated osteonecrosis of the jaw. Drug related risk factors a bisphosphonate potency. Medicationrelated osteonecrosis of the jaw mronj, which was first described in 2002, is a relatively uncommon but potentially serious side effect of treatment with osteoclast inhibitors, such as intravenous highpotency bisphosphonates and denosumab, which decrease the risk of skeletalrelated events in patients with cancer and metastatic bone disease.
Bisphosphonatesinduced osteonecrosis of the jaws core. Effect of lowlevel laser irradiation on bisphosphonate. One centres on the bisphosphonate induced osteoclast inhibition and the other explains the process. Bisphosphonates bps is widely used as the first line of treatment choice for osteoporosis, pagets disease of bone, bone cancer metastasis and hypercalcemia of malignancy. The aim of this study is to describe the radiological features of bisphosphonate osteonecrosis bon in order to aid its prompt recognition. It may lead to surgical complication in the form of impaired wound healing following oral and maxillofacial surgery, periodontal surgery, or endodontic therapy. Oral and intravenous bisphosphonate induced osteonecrosis. Since intravenous administration leads to a higher drug exposure than the oral route, osteonecrosis related to oral bisphosphonate therapy is less common than that of related to intravenous forms such as zolendronate which is also more potent than oral bisphosphonates.
The actions of the commonly prescribed oral bisphosphonates are discussed. Hyperbaric oxygen in addition to antibiotic therapy is effective for bisphosphonate induced osteonecrosis of the jaw in a patient with multiple myeloma. Bisphosphonaterelated osteonecrosis of jaw bronj is defined as an area of exposed bone or bone that can be probed through an intraoral or extraoral fistula in maxillofacial region that has persisted for more than 8 weeks in a patient currently or previously treated with bisphosphonates bps and no history of radiation therapy or obvious metastatic disease to this area. It has been speculated that the medication, especially longterm i. Rarely found in the jaws is a steroid induced form of osteonecrosis that is much more common in long bones, and, unlike the bisphosphonate induced necrotic bone, it almost never produces exposed bone. Bisphosphonate molecules preferentially bind to calcium ions. Care guidelines are based on expert opinion but clinical decisions are left up to practitioners. In 2002, the food and drug administration fda received first reports related to several patients with cancer, treated with the iv bisphosphonates bp, who developed osteonecrosis of the jaw. Bisphosphonates have an important role in the prophylaxis and treatment of postmenopausal and corticosteroid osteoporosis. Bisphosphonate medications bisphosphonates are a class of medications which include pamidronate aredia.
The structure and function of bisphosphonates, and their role in the development of bronj will be discussed, as will the possible. Two broad theories have been articulated to explain the pathogenesis if bisphosphonate related osteonecrosis of the jaws bronj. Bisphosphonates and osteonecrosis of the jaws australian. Bisphosphonates are a class of drugs that reduce the rate of bone turnover. The introduction of bisphosphonates has increased in the last decade following their indication for metastatic bone diseases, osteoporosis, hypercalcaemia of malignancy and pagets disease. It is important to recognize osteonecrosis of the jaws in patients treated with bisphosphonates because an early diagnosis can make a significant difference to the outcome of the disease. Current prospective management of patients with osteonecrosis. Prospective study of 80 patients with multiple myeloma and other malignancies. Medication related osteonecrosis of the jaw wikipedia. Prospective study of 80 patients with multiple myeloma and other malignancies thacharot boonyapakorn a, ingrid schirmer a, peter a.
May 19, 2010 in department of maxillofacial surgery, from january 2003 to september 2009, it has been observed 84 patients with onj. Oral bisphosphonates and the risk for osteonecrosis of the jaw. A multidisciplinary approach pdf, epub, docx and torrent then this site is not for you. Bisphosphonates and bisphosphonateinduced osteonecrosis of. Pamidronate aredia and zoledronate zometa induced avascular necrosis of the jaws. Oral bisphosphonates and the risk for osteonecrosis of the. The controversy of osteonecrosis of the jaws and bisphosphonates is a recent and growing problem. History, etiology, prevention, and treatment, second edition robert e. Osteonecrosis of the jaws onj have been recently linked to bip treatment. Bisphosphonate bp induced osteonecrosis of the jaws is a rare complication of bisphosphonates bp therapy.
Bisphosphonateinduced osteonecrosis of the jaws, bone. A complication of their use is osteonecrosis of the jaw. Bisphosphonates osteonecrosis osteonecrosis of the jaws cancer therapy metastasis bone necrosis. Pdf bisphosphonateinduced osteonecrosis of the jaws bionj. The largest store of calcium in the human body is in bones, so bisphosphonates accumulate to a high concentration only in bones. Pathophysiology of bisphosphonates associated osteonecrosis of the jaw r01 pa072. Selfhealing lesion of bisphosphonate induced osteonecrosis of. This complication is poorly understood and is called bisphosphonateinduced osteonecrosis of the jaw bioj. Use of ultrasonic bone surgery piezosurgery to surgically treat. To elucidate the mechanisms of the onset of bronj, the present. Bisphosphonates and osteonecrosis of the jaw bisphosphonate medications are linked to a risk of osteonecrosis of the jaw.
Bisphosphonate induced osteonecrosis of the jaws is the correct term for this real drug complication that most dental practitioners face. Strategies to minimise the risk of osteonecrosis of the jaws with bisphosphonates are unclear. The aim of this study was to describe the incidence and risk factors of onj in patients with breast cancer or gynecological malignancies receiving bisphosphonates bp. Osteonecrosis of the jaws and bisphosphonate therapy s. Oral and intravenous bisphosphonateinduced osteonecrosis of.
Abstractthe literature describes an increasing presence of bisphosphonate induced. Patients treated with bisphosphonates because of bone metastases have been shown to develop osteonecrosis of the jaws. May 28, 2010 bisphosphonates bps are boneremodeling inhibitors that are used to manage bone metastases and osteoporosis. In the present study, we examined the histologic findings of these cases. Risk factors, recognition, prevention, treatment of bisphosphonate induced osteonecrosis of the jaws. Bisphosphonates and osteonecrosis of the jaws journal of. Given the widespread use of bisphosphonates in clinical practice, even a very low incidence of oral osteonecrosis in bisphosphonate users should be considered a public emergency. Bisphosphonateinduced osteonecrosis of the jaw onj. Patients receiving oral bisphosphonate therapy are at a considerably lower risk of bronj than cancer. Bisphosphonates and osteonecrosis of the maxilla qjm. Recently three bisphosphonates, pamidronate aredia.
Mar 29, 2008 osteonecrosis of the jaws associated with bisphosphonate therapy was first identified in 2003 as a condition typified by exposed bone that does not heal after 8 weeks. The aim of this study was to detail the clinical efficacy of lowlevel laser therapy lllt for the management of bisphosphonate induced osteonecrosis of the jaws onjbp. However, despite this evidence, many patients at risk for osteoporosis are not screened or treated. The change is justified to accommodate the growing number of osteonecrosis cases involving the maxilla and. Oral bisphosphonate associated osteonecrosis of the jaws. Bisphosphonates and bisphosphonate induced osteonecrosis. Medicationrelated osteonecrosis of the jaw2014 update.
Bisphosphonate associated osteonecrosis bon is a rare complication that almost exclusively affects the jaws. The prolonged use of bisphosphonates has been shown to cause a condition termed bisphosphonate related osteonecrosis of the jaws bronj. It also shows that there is an increase in cases of bisphosphonates induced steonecrosis of the jaws in patients using longterm oral preparations, which upports the hypothesis of a cumulative effect of these products involved in disease pathogenesis. This form of osteonecrosis has been termed bisphosphonate induced osteonecrosis of the jaw bionj.
Clinical findings of bisphosphonate related osteonecrosis of the jaw bronj bisphosphonate related osteonecrosis of the jaw bronj is an area of uncovered bone in the maxillofacial region that did not heal within 8 weeks after identification by health care provider, in a patient who was receiving or had been exposed to bisphosphonate therapy bpt without previous radiation. M arx 8 defines bisphosphonate induced osteonecrosis of the jaws as a condition characterized by exposure of bone in the mandible or maxilla persisting for more than 8 weeks in a patient who has taken or currently is taking a bisphosphonate and who has no history of radiation therapy to the jaws. Plateletrich plasma in treatment of zoledronic acid. Bisphosphonates and bisphosphonate induced osteonecrosis of the jaws. Osteonecrosis of the jaws caused by bisphosphonate. Bisphosphonates are a class of drug used in prevention and cure of bone diseases such as malignancy or bone metabolic diseases.
Shortly after the turn of the century, a variety of case reports described a necrosis of the jaw bone in patients using bisphosphonates. Pdf bisphosphonateinduced osteonecrosis of the jaw. Updates on bisphosphonates and potential pathobiology of. This case report presents a patient who presented to the ent department with sinus symptoms from oroantral fistulae following bisphosphonate use requiring surgery. Bisphosphonaterelated osteonecrosis of the jaw bronj is a serious sideeffect of treatment with the new generation of bisphosphonates. Dental care protocols bisphosphonate medications are linked to a risk of osteonecrosis of the jaw. While many clinicians currently recognize that bisphosphonate usage is associated with osteonecrosis of the jaws.
Osteonecrosis of jaws onj might be old, dating back a century in the form of phossy jaw. The authors describe a case of osteonecrosis of the jaws in a patient receiving longterm bisphosphonate therapy for cancer. Plateletrich plasma prp plays an important role in bone biology by enhancing bone repair and regeneration. Oral and intravenous bisphosphonateinduced osteonecrosis. Osteonecrosis of the jaw and bisphosphonates the bmj. Bisphosphonateinduced osteonecrosis of the jaw request pdf. Osteonecrosis of the jaws onj affects the mandible about twice as often as the maxilla, and has emerged as a complication of bisphosphonate treatment. Surgical management of bisphosphonate related osteonecrosis of the jaws bronj has been performed in an attempt to increase healing rates of the affected cases. The special committee favors the term medicationrelated osteonecrosis of the jaw mronj. Osteonecrosis of the jaws is an increasingly recognised complication of bisphosphonate therapy. It presents as painful exposed bone in the maxillary or mandibular alveolus with intra or extraoral.
Despite these benefits, osteonecrosis of the jaws has recently emerged as a significant complication in a subset of patients receiving these drugs. Nonexposed osteonecrosis of the jaws neonj does not fit into the current definition of osteonecrosis, which requires exposed bone. Medicationrelated osteonecrosis of the jaw mon, mronj is progressive death of the jawbone in a person exposed to a medications known to increase the risk of disease, in the absence of a previous radiation treatment. A modification of the classification of bisphosphonate induced osteonecrosis of the jaws onj is proposed. Oroantral fistula from bisphosphonate induced osteonecrosis. Histopathology of scrapings ruled out plasmacytoma. As similarities between this disorder and infected osteoradionecrosis iorn are described, both lesions were compared. Oral and intravenous bisphosphonate induced osteonecrosis of the jaws. However, a causeandeffect relationship has not been established, and most of the reported cases have been in patients with cancer who were receiving much higher doses than those used to treat osteoporosis or paget disease of bone. Bisphosphonates is a group of inorganic pyrophosphates analogues that suppress bone resorption by inducing osteoclast inactivation, being.
1148 458 438 12 264 944 1344 598 355 1362 898 1030 37 35 282 655 199 1159 120 806 1326 234 91 580 25 522 682 747 414 879 55 1461 1524 367 1217 963 627 1481 68 1027 1136 634 120